Sector | Healthcare |
Industry | - |
Day Range | 2.19 | 2.22 |
52-Wk Range | - | - |
Last Close | 2.19 |
Mkt Cap (m) | 32.95 |
Dividend yield | - |
ISIN | FI0009005482 |
Volume | 21,478.00 |
Exchange Venue | HEL |
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products and systems for diagnostic analysis for the use of research institutions, health care and industry.
Price/Earning | - |
Price/Book | 3.43 |
Price/Sales | 4.09 |
P/CF | - |
Rev Growth (3 year avg) | - |
EPS Growth (3 year avg) | - |
Operating Margin % | - |
Net Margin % | - |
Return on Equity | - |
Debt/Equity | - |
en 07/09/2018 |
en 31/12/2019 |
Please refer to the below issuer website for further documents.
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Revenue (m) | 6.05 | 8.20 | 8.98 | 9.93 | 10.05 | - |
Operating Income (m) | -3.56 | -3.17 | -1.63 | -1.96 | -1.41 | - |
Net Income (m) | -2.92 | -3.30 | 6.14 | -2.14 | -1.42 | - |
Basic EPS | -0.20 | -0.22 | 0.42 | -0.14 | -0.09 | - |
Avg. Diluted Shares Outstanding (m) | 14.70 | 15.05 | 14.94 | 15.02 | 15.01 | - |
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Current Assets (m) | 8.88 | 10.59 | 11.35 | 12.23 | 13.21 | - |
Non Current Assets (m) | 2.85 | 2.40 | 7.54 | 5.66 | 4.16 | - |
Total Assets (m) | 11.73 | 12.99 | 18.90 | 17.89 | 17.37 | - |
Current Liabilities (m) | 1.24 | 1.82 | 1.28 | 1.57 | 2.38 | - |
Total Liabilities (m) | - | - | - | - | - | - |
Total Equity (m) | 10.31 | 10.75 | 17.24 | 15.89 | 14.58 | - |
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Operating Cash Flows (m) | -3.15 | -2.46 | -0.94 | -0.09 | 0.08 | - |
Capital Expenditure (m) | -0.22 | -0.09 | -0.17 | -0.02 | -0.05 | - |